What We Know about Primary Metastatic Breast Cancer: Pathological Characteristics and Outcome over a

来源 :2013第六届世界癌症大会 | 被引量 : 0次 | 上传用户:wren200
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
  Approximately 6% of patients with breast cancer have distant metastases (pmBC) at the time of the initial diagnosis.The pathological characteristics of these tumors are unclear.The aim of this exploratory analysis in patients with pmBC, treated in 8 German breast cancer centers between 1998 and 2010, was to examine the specifics of pmBC, overall survival rate over defined time and to investigate the effect of new therapy options.Phenotypes were defined using the following immune-histochemical markers: estrogen receptor, progesterone receptor and human epidermal growth factor receptor 2.For examining of outcome the date of diagnosis was used to define 2 specifically chosen 5-year periods: 1998-2002 and 2003-2007.
其他文献
Human papillomavirus (HPV) is associated with different malignancies but its role in the pathogenesis of ovarian cancer is controversial.This study investigated the possible role of human papillomavir
会议
Biobank is a type of biorepository that stores biological samples for use in research.It plays a major role in prognosis, diagnosis and treatment of human diseases.The development of translational med
会议
Imatinib (Gleevec(R), Glivec(R)), a selective inhibitor of ABL, KIT, and PDGFRA/B, is the first line targeted therapy for gastrointestinal stromal tumor (GIST).Unfortunately, the median-progressionfre
会议
1.Background: Personalized Medicine requires tools that allow to investigate the expression of molecular markers, in particular of signal transduction cascades, on the single-cell level to understand
会议
Resistance and recurrence of breast cancer following initial successful endocrine treatment is of major clinical concern.Screening for drug treatment efficacy in vitro requires reliable measurement of
会议
Objective: Establishing patient-derived subrenal capsule (SRC) xenografls in pancreatic cancer (PC) as a novel pre-clinical model for predicting chemotherapeutic responsiveness.Methods: 24 PC patients
会议
In view of the fact that defects in immune response often correlate with poor prognosis, research in recent years has focused on the task of precisely describing the status and function of the immune
会议
Treatment of pancreatic cancer with gemcitabine or 5-fluouracil (5-FU) often fails due to rapid development of resistance during chemotherapy.Recent studies have suggested that some ATPbinding Cassett
会议
Thioredoxin (TRX 1), a 12-kDa protein with redox-active dithiol in the active site-Cys-Gly-ProCys-, is ubiquitously present in humans and other species.TRX1 is a defensive protein induced by various s
会议
Bone is one of the most common sites of relapse for breast cancer.The subset of breast cancer patients with isolated bone metastasis (IBM) forms a clinically distinct group that often has a favorable
会议